skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:060379/0089   Pages: 11
Recorded: 06/09/2022
Attorney Dkt #:37726-01000/US
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 7
1
Patent #:
Issue Dt:
01/18/2011
Application #:
11527691
Filing Dt:
09/27/2006
Publication #:
Pub Dt:
04/12/2007
Title:
TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME
2
Patent #:
Issue Dt:
12/27/2011
Application #:
12295618
Filing Dt:
09/30/2008
Publication #:
Pub Dt:
11/26/2009
Title:
PROCESS FOR PREPARING TETRAHYDROQUINOLINE DERIVATIVES
3
Patent #:
Issue Dt:
04/17/2012
Application #:
12911149
Filing Dt:
10/25/2010
Publication #:
Pub Dt:
02/17/2011
Title:
TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME
4
Patent #:
Issue Dt:
05/19/2020
Application #:
15117154
Filing Dt:
08/05/2016
Publication #:
Pub Dt:
06/29/2017
Title:
Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases
5
Patent #:
Issue Dt:
10/30/2018
Application #:
15503686
Filing Dt:
02/13/2017
Publication #:
Pub Dt:
09/21/2017
Title:
Process for Preparing Synthetic Intermediates for Preparing Tetrahydroquinoline Derivatives
6
Patent #:
Issue Dt:
05/28/2019
Application #:
15507669
Filing Dt:
02/28/2017
Publication #:
Pub Dt:
01/04/2018
Title:
PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS
7
Patent #:
Issue Dt:
05/25/2021
Application #:
16844996
Filing Dt:
04/09/2020
Publication #:
Pub Dt:
07/23/2020
Title:
Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases
Assignor
1
Exec Dt:
10/27/2021
Assignee
1
GOOIMEER 2-35
NAARDEN, NETHERLANDS 1411 DC
Correspondence name and address
DANQIONG SUN
FENWICK & WEST LLP
801 CALIFORNIA STREET
MOUNTAIN VIEW, CA 94041

Search Results as of: 04/30/2024 03:35 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT